Top Markets
#1 QuantixAI QuantixAI +63.61%
#2 Versatize Coin Versatize Coin +40.00%
#3 MowCat MowCat +31.47%
#4 GEKKO GEKKO +30.62%
#5 Pons Pons +30.58%
#6 UnifAI Network UnifAI Network +29.65%
#7 Prom Prom +27.62%
#8 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +27.34%
#9 MarsCoin MarsCoin +24.92%
#10 Kinesis Silver Kinesis Silver +24.10%
Coin of the day
QuantixAI QuantixAI
Settings
Language
ENGLISH
Currency
USD
Theme
JETEMA, Co., Ltd. JETEMA, Co., Ltd.

JETEMA, Co., Ltd.

216080
Rank in Stocks #20317
Based in Wonju, South Korea, JETEMA, Co., Ltd. is a dynamic bio-venture firm... Based in Wonju, South Korea, JETEMA, Co., Ltd. is a dynamic bio-venture firm dedicated to the innovation and development of pharmaceuticals and medical technologies. Their comprehensive portfolio encompasses a range of advanced solutions, including aesthetic treatments such as botulinum toxins, dermal fillers, and specialized anti-aging remedies, along with medical lifting threads. Additionally, they provide laser surgical instruments and hyaluronic acid masks for skincare.
Share Price
$3.60
Market Cap
$133.80M
Change (1 day)
3.38%
Change (1 year)
-18.00%
Country
KR
Trade JETEMA, Co., Ltd. (216080)

Category

Healthcare
P/S ratio for JETEMA, Co., Ltd. (216080)
P/S ratio as of 2026 TTM: 0
According to JETEMA, Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for JETEMA, Co., Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US